[HTML][HTML] Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders

P Hu, K Li, X Peng, Y Kan, H Li, Y Zhu, Z Wang, Z Li… - Nutrients, 2023 - mdpi.com
Lipid metabolic diseases have substantial morbidity and mortality rates, posing a significant
threat to human health. PPARα, a member of the peroxisome proliferator-activated receptors …

Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders

P Hu, K Li, X Peng, Y Kan, H Li, Y Zhu, Z Wang, Z Li… - Nutrients, 2023 - europepmc.org
Lipid metabolic diseases have substantial morbidity and mortality rates, posing a significant
threat to human health. PPARα, a member of the peroxisome proliferator-activated receptors …

[HTML][HTML] Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders

P Hu, K Li, X Peng, Y Kan, H Li, Y Zhu, Z Wang, Z Li… - Nutrients, 2023 - ncbi.nlm.nih.gov
Lipid metabolic diseases have substantial morbidity and mortality rates, posing a significant
threat to human health. PPARα, a member of the peroxisome proliferator-activated receptors …

Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders

P Hu, K Li, X Peng, Y Kan, H Li, Y Zhu, Z Wang, Z Li… - Nutrients, 2023 - search.proquest.com
Lipid metabolic diseases have substantial morbidity and mortality rates, posing a significant
threat to human health. PPARα, a member of the peroxisome proliferator-activated receptors …

Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders

P Hu, K Li, X Peng, Y Kan, H Li, Y Zhu, Z Wang… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Lipid metabolic diseases have substantial morbidity and mortality rates, posing a significant
threat to human health. PPARα, a member of the peroxisome proliferator-activated receptors …

Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders.

P Hu, K Li, X Peng, Y Kan, H Li, Y Zhu, Z Wang… - …, 2023 - search.ebscohost.com
Lipid metabolic diseases have substantial morbidity and mortality rates, posing a significant
threat to human health. PPARα, a member of the peroxisome proliferator-activated receptors …

Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders.

P Hu, K Li, X Peng, Y Kan, H Li, Y Zhu, Z Wang, Z Li… - Nutrients, 2023 - europepmc.org
Lipid metabolic diseases have substantial morbidity and mortality rates, posing a significant
threat to human health. PPARα, a member of the peroxisome proliferator-activated receptors …